Decitabine + Cedazuridine 35 mg + 100mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 35 mg + 100mg
Reference Brands: Inqovi (USA/EU)
Category: Oncology Cancer Care
Decitabine/cedazuridine is an oral fixed-dose combination used for the treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia. Cedazuridine improves oral absorption of decitabine by inhibiting its breakdown, allowing patients to receive effective decitabine therapy without injections.
Decitabine + Cedazuridine — third party manufacturing & bulk supply
Decitabine + Cedazuridine 35 mg + 100mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Decitabine + Cedazuridine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Decitabine + Cedazuridine →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Decitabine + Cedazuridine is used for treating myelodysplastic syndromes and chronic myelomonocytic leukemia. Decitabine provides hypomethylating activity, while cedazuridine increases its oral absorption by inhibiting cytidine deaminase, allowing decitabine to achieve therapeutic systemic levels through an oral dosage.
Decitabine + Cedazuridine is made from two active components: decitabine, a DNA hypomethylating agent, and cedazuridine, an inhibitor of cytidine deaminase. Together, they enable effective oral administration of decitabine.
The trade name is Inqovi.
Inqovi is manufactured by Taiho Oncology and Astex Pharmaceuticals.
The generic name is decitabine and cedazuridine.
The brand name is Inqovi.
Decitabine + Cedazuridine is manufactured in the United States and Canada under Taiho and Astex production facilities for regulated markets.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
